Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Reactivity of Clopidogrel and Aspirin With or Without Omeprazole in Patients With Diabetes Mellitus and Coronary Artery Disease (POC-DM Trial)
TCTR20260714003Phase 3Completed
- Sponsor
- Royal College of Physicians of Thailand
- Start
- Sep 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel, aspirin, omeprazole in type 2 diabetes mellitus (T2DM), coronary arteriosclerosis, sponsored by Royal College of Physicians of Thailand. Started Sep 2024; status: completed.
02
Drugs
clopidogrelaspirinomeprazole
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on TCTR20260714003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260714003.